Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Current estimates suggest: Approximately 900,000 people living with dementia in the UK (Alzheimer's Society) Two-thirds of these have Alzheimer's disease (approximately 600,000 people) Projected to rise to 1.6 million by 2040 as the population ages Healthcare and social care costs exceed 26 billion annually Informal caregiving burden is enormous, affecting family members' employment and wellbeing This disease burden explains why the NHS and research community continue pursuing disease-modifying treatments, despite repeated setbacks like the LIFT-AD trial failure
(PubMed) Douaud G, Refsum H, de Jager CA, et al
99%+ Purity Lab Verified Lyophilized For Stability Research Grade Not for Human Use 1 In stock COA 99% Batch SEQ-BPC157-965 Tissue Research Description Body Protection Compound investigated in in vitro tissue repair studies and gastrointestinal research models
How does the Precision Peptide Genetic Test improve weight loss outcomes
